vs
Side-by-side financial comparison of Elme Communities (ELME) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
Elme Communities is the larger business by last-quarter revenue ($62.1M vs $47.7M, roughly 1.3× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -198.9%, a 194.1% gap on every dollar of revenue. On growth, Elme Communities posted the faster year-over-year revenue change (1.7% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $7.2M). Over the past eight quarters, Elme Communities's revenue compounded faster (2.7% CAGR vs -20.2%).
Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
ELME vs IRWD — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $47.7M |
| Net Profit | $-123.5M | $-2.3M |
| Gross Margin | 61.1% | — |
| Operating Margin | -183.3% | 14.3% |
| Net Margin | -198.9% | -4.8% |
| Revenue YoY | 1.7% | -47.3% |
| Net Profit YoY | -4058.7% | -200.9% |
| EPS (diluted) | $-1.40 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $47.7M | ||
| Q3 25 | $62.1M | $122.1M | ||
| Q2 25 | $62.1M | $85.2M | ||
| Q1 25 | $61.5M | $41.1M | ||
| Q4 24 | $61.3M | $90.5M | ||
| Q3 24 | $61.1M | $91.6M | ||
| Q2 24 | $60.1M | $94.4M | ||
| Q1 24 | $59.5M | $74.9M |
| Q4 25 | — | $-2.3M | ||
| Q3 25 | $-123.5M | $40.1M | ||
| Q2 25 | $-3.6M | $23.6M | ||
| Q1 25 | $-4.7M | $-37.4M | ||
| Q4 24 | $-3.0M | $2.3M | ||
| Q3 24 | $-3.0M | $3.6M | ||
| Q2 24 | $-3.5M | $-860.0K | ||
| Q1 24 | $-3.6M | $-4.2M |
| Q4 25 | — | — | ||
| Q3 25 | 61.1% | — | ||
| Q2 25 | 63.5% | — | ||
| Q1 25 | 64.2% | — | ||
| Q4 24 | 62.9% | — | ||
| Q3 24 | 63.5% | — | ||
| Q2 24 | 63.4% | — | ||
| Q1 24 | 63.5% | — |
| Q4 25 | — | 14.3% | ||
| Q3 25 | -183.3% | 61.8% | ||
| Q2 25 | 9.6% | 53.2% | ||
| Q1 25 | 7.8% | -70.7% | ||
| Q4 24 | 10.4% | 34.8% | ||
| Q3 24 | 11.0% | 28.0% | ||
| Q2 24 | 9.8% | 26.5% | ||
| Q1 24 | 7.5% | 14.7% |
| Q4 25 | — | -4.8% | ||
| Q3 25 | -198.9% | 32.8% | ||
| Q2 25 | -5.7% | 27.7% | ||
| Q1 25 | -7.6% | -90.9% | ||
| Q4 24 | -4.9% | 2.5% | ||
| Q3 24 | -4.9% | 4.0% | ||
| Q2 24 | -5.8% | -0.9% | ||
| Q1 24 | -6.1% | -5.6% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-1.40 | $0.23 | ||
| Q2 25 | $-0.04 | $0.14 | ||
| Q1 25 | $-0.05 | $-0.23 | ||
| Q4 24 | $-0.04 | $0.03 | ||
| Q3 24 | $-0.03 | $0.02 | ||
| Q2 24 | $-0.04 | $-0.01 | ||
| Q1 24 | $-0.04 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $908.9M | $-261.8M |
| Total Assets | $1.7B | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | $7.1M | $140.4M | ||
| Q2 25 | $4.8M | $92.9M | ||
| Q1 25 | $6.4M | $108.5M | ||
| Q4 24 | $6.1M | $88.6M | ||
| Q3 24 | $4.8M | $88.2M | ||
| Q2 24 | $5.6M | $105.5M | ||
| Q1 24 | $4.2M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | — | $-261.8M | ||
| Q3 25 | $908.9M | $-264.2M | ||
| Q2 25 | $1.0B | $-308.2M | ||
| Q1 25 | $1.1B | $-334.1M | ||
| Q4 24 | $1.1B | $-301.3M | ||
| Q3 24 | $1.1B | $-311.3M | ||
| Q2 24 | $1.1B | $-321.7M | ||
| Q1 24 | $1.1B | $-330.5M |
| Q4 25 | — | $396.9M | ||
| Q3 25 | $1.7B | $396.1M | ||
| Q2 25 | $1.8B | $342.9M | ||
| Q1 25 | $1.8B | $327.2M | ||
| Q4 24 | $1.8B | $350.9M | ||
| Q3 24 | $1.9B | $389.5M | ||
| Q2 24 | $1.9B | $395.6M | ||
| Q1 24 | $1.9B | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.9M | $74.6M |
| Free Cash FlowOCF − Capex | $7.2M | $74.6M |
| FCF MarginFCF / Revenue | 11.6% | 156.3% |
| Capex IntensityCapex / Revenue | 14.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $86.7M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $74.6M | ||
| Q3 25 | $15.9M | $47.6M | ||
| Q2 25 | $29.8M | $-15.1M | ||
| Q1 25 | $16.2M | $20.0M | ||
| Q4 24 | $95.2M | $15.2M | ||
| Q3 24 | $20.7M | $9.9M | ||
| Q2 24 | $28.9M | $33.5M | ||
| Q1 24 | $21.2M | $45.0M |
| Q4 25 | — | $74.6M | ||
| Q3 25 | $7.2M | $47.6M | ||
| Q2 25 | $21.1M | $-15.1M | ||
| Q1 25 | $10.5M | $19.9M | ||
| Q4 24 | $47.9M | — | ||
| Q3 24 | $8.8M | $9.9M | ||
| Q2 24 | $21.0M | $33.4M | ||
| Q1 24 | $7.6M | $44.9M |
| Q4 25 | — | 156.3% | ||
| Q3 25 | 11.6% | 39.0% | ||
| Q2 25 | 34.1% | -17.7% | ||
| Q1 25 | 17.1% | 48.4% | ||
| Q4 24 | 78.1% | — | ||
| Q3 24 | 14.4% | 10.8% | ||
| Q2 24 | 34.9% | 35.4% | ||
| Q1 24 | 12.8% | 60.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 14.0% | 0.0% | ||
| Q2 25 | 14.0% | 0.0% | ||
| Q1 25 | 9.2% | 0.1% | ||
| Q4 24 | 77.4% | 0.0% | ||
| Q3 24 | 19.4% | 0.0% | ||
| Q2 24 | 13.1% | 0.1% | ||
| Q1 24 | 22.9% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
IRWD
Segment breakdown not available.
